Protagonist Therapeutics (PTGX)

• Market cap: $8.73B
• 1 day: 0.24%
• 5 days: -4.25%
• 1 month: 11.14%
• 3 months: 35.76%
• 6 months: 64.96%
• Year to date: 55.72%
• 1 year: 152.62%
• 5 years: 190.09%
• 10 years: 1,060.34%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Employees: 131